Annovis Bio Inc. to Showcase Alzheimer’s Research at AAIC 2025
Annovis Bio Inc. (NYSE: ANVS), a leader in developing therapies for neurodegenerative diseases, is set to present its latest research findings at the Alzheimer’s Association International Conference (AAIC) 2025 in...